Luna Innovations Overview
Valuation check: LUNA's ROE is -11.07%, below the Healthcare sector average of 29.39%.
Get informed when a big investor buys or sells
+ Follow-11.07%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
Luna Innovations (LUNA) currently reports a ROE of -11.07%. That is below the Healthcare sector average of 29.39%. Use the charts on this page to explore Luna Innovations's ROE history and peer comparisons.
Luna Innovations's ROE of -11.07% is lower than the Healthcare sector average of 29.39%. That is roughly 137.7% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but Luna Innovations's current -11.07% should be judged against Healthcare norms (sector average: 29.39%) and against LUNA's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of -11.07%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 29.39%. From there, open related valuation or income-statement pages for Luna Innovations, and consider following LUNA for alerts when major investors trade the stock.
Luna Innovations is classified in the Healthcare sector. On ROE, it currently shows -11.07% versus a sector average near 29.39%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing LUNA with unrelated industries.
